J.C. Penney delivered the latest dismal retail news, reporting a much larger-than-expected loss as same-store sales fell 32 percent. Shares skidded after-hours.
Mad Money host Jim Cramer explains how not to get drawn into poor investing ideas.
If your portfolio is awash in red marks and minus signs, perhaps you’re making this mistake.
Looking to speculate in biopharma stocks? Cramer's done some homework and he likes this one.
Alkermes is a pharmaceutical company with a portfolio of over 20 commercial drug products. Richard F. Pops, Alkermes CEO, weighs in.
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
The Mad Money host was talking about the 12th largest independent oil and gas exploration and production company.
Mark E. Ellis, Linn Energy chairman, president & CEO, says his company's hedges allow them to take very little commodity price risk.
Aria uses structure-based drug design to identify molecules able to overcome resistance in therapy. Dr. Harvey Berger, Aria Pharmaceuticals chairman & CEO, offers insight on earnings.
Is there a massive storm brewing in the market? Jim Cramer thinks that kind of talk is simply hot air.
Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.
Mad Money host Jim Cramer weighs in on the market high.
The Fast Money traders share their final trades of the day.
TV legend Regis Philbin comes to Fast Money to talk about stocks.
CNBC's Courtney Reagan has an update from JC Penney's conference call. Stacey Widlitz, SW Retail Advisors, says the retailer's CEO has conceded to making a mistake.
Consumer staples are on fire, with the Fast Money team. Luxury names are a mixed bag meanwhile.
CNBC's Courtney Reagan has an update on JC Penney earnings Meanwhile the Fast Money traders debate whether the transports \are still a good buy. And Mark Mulholland, portfolio manager at Matthew 25 Fund, says it will take a year to get Apple back on track.
The Dow has its fourth-straight triple-digit ove for the first time since November 2011, with the Fast Money traders.
CNBC's Melissa Lee and the Fast Money traders discuss the day's top trades and the stocks they'll be watching Thursday.
$85 billion of spending cuts in defense and discretionary could lead to job cuts and a contraction of growth. CNBC's Maria Bartiromo shares her observation.